The clincial utility of circulating free DNA (cfDNA) analysis in non-small cell lung cancer (NSCLC) in the United Kingdom

被引：0
|
作者：
Greystoke, A. [1 ]
Carter, M. [2 ]
Griffiths, W. [1 ]
Laviste, G. [2 ]
Ortega-Franco, A. [2 ]
Rafee, S. [2 ]
Hannaway, N. [1 ]
Bridgewood, A. [1 ]
Hall, S. [1 ]
Blackhall, F. H. [2 ]
机构：
[1] Freeman Hosp NHS Fdn Trust Northern Ctr Canc Care, Med Oncol Dept, Newcastle Upon Tyne, Tyne & Wear, England
[2] Christie NHS Fdn Trust, Med Oncol, Manchester, Lancs, England
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.1651
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1337P
引用
收藏
页码：S859 / S859
页数：1
相关论文
共 50 条
  • [21] Possible application of circulating free tumor DNA in non-small cell lung cancer patients
    Karachaliou, Niki
    Sosa, Aaron E.
    Angel Molina, Miguel
    Centelles Ruiz, Margarita
    Rosell, Rafael
    JOURNAL OF THORACIC DISEASE, 2017, 9 : S1364 - S1372
  • [22] Role of circulating-tumor DNA analysis in non-small cell lung cancer
    Jiang, Tao
    Ren, Shengxiang
    Zhou, Caicun
    LUNG CANCER, 2015, 90 (02) : 128 - 134
  • [23] NON-SMALL CELL LUNG CANCER (NSCLC) IN THE UNITED STATES DEPARTMENT OF DEFENSE
    Carter, Corey A.
    Satram-Hoang, Sacha
    Gunuganti, Ashok
    Reyes, Carolina
    Goertz, Hans-Peter
    Gallagher, Christopher
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S985 - S985
  • [24] Prognostic Role of Circulating Tumor DNA (ctDNA) and Immune Cell Biomarkers in Non-Small Cell Lung Cancer (NSCLC)
    Chae, Y. K.
    Agte, S.
    Davis, A.
    Pan, A.
    Simon, N.
    Mohindra, N.
    Villaflor, V.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2242 - S2242
  • [25] CLINICAL UTILITY OF CIRCULATING SERUM AND PLASMA BIOMARKERS FOR PERSONALISED RADIOTHERAPY TREATMENT OF NON-SMALL CELL LUNG CANCER (NSCLC)
    Faivre-Finn, Corinne
    Blackhall, Fiona
    Backen, Alison
    Hodgson, Clare
    Koh, Pek
    Dean, Emma
    Priest, Lynsey
    Dive, Caroline
    Renehan, Andrew
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S501 - S501
  • [26] Evaluating circulating cell-free DNA and DNA integrity index as biomarkers in non-small cell lung cancer
    Ezzeldin, Nada
    El-Lebedy, Dalia
    Hassan, Mirhane
    Shalaby, Alaa Omar
    Hussein, Sabah Ahmed Mohamed
    Gharib, Ahmed Mohamed
    Hamdy, Gehan
    Mohammed, Asmaa Mahmoud
    Ramadan, Abeer
    Sobeih, Mohamed Emam
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2024, 36 (01)
  • [27] Circulating cell free DNA during chemo-radiotherapy in non-small cell lung cancer patients
    Nygaard, L.
    Ahlborn, L.
    Persson, G.
    Chandrananda, D.
    Langer, J.
    Fischer, B. M.
    Aznar, M.
    Langer, S.
    Gabrielaite, M.
    Kjaer, A.
    Rosenfeld, N.
    Mouliere, F.
    Ostrup, O.
    Vogelius, I.
    Bentzen, S.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S747 - S748
  • [28] Serum circulating cell free DNA as potential diagnostic and prognostic biomarker in non-small cell lung cancer
    Alhanafy, A.
    El Shafei, S.
    Habib, M.
    Abdellatif, R.
    Haggag, M.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : S17 - S18
  • [29] β-catenin in non-small cell lung cancer (NSCLC)
    Swinson, DEB
    Lolljee, J
    Edwards, JG
    Jones, JL
    Cox, G
    Richardson, D
    O'Byrne, KJ
    BRITISH JOURNAL OF CANCER, 2002, 86 : S59 - S60
  • [30] Micrometastases in non-small cell lung cancer (NSCLC)
    Passlick, B
    LUNG CANCER, 2001, 34 : S25 - S29
12345